PT1175224E - Terapeutica de combinacao contra hiv com interferao-alfa peguilado e um antagonista de ccr5 - Google Patents

Terapeutica de combinacao contra hiv com interferao-alfa peguilado e um antagonista de ccr5

Info

Publication number
PT1175224E
PT1175224E PT00928604T PT00928604T PT1175224E PT 1175224 E PT1175224 E PT 1175224E PT 00928604 T PT00928604 T PT 00928604T PT 00928604 T PT00928604 T PT 00928604T PT 1175224 E PT1175224 E PT 1175224E
Authority
PT
Portugal
Prior art keywords
peguiled
interphant
alpha
combination therapy
ccr5 antagonist
Prior art date
Application number
PT00928604T
Other languages
English (en)
Portuguese (pt)
Inventor
Mark A Laughlin
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PT1175224E publication Critical patent/PT1175224E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT00928604T 1999-05-04 2000-05-01 Terapeutica de combinacao contra hiv com interferao-alfa peguilado e um antagonista de ccr5 PT1175224E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30489799A 1999-05-04 1999-05-04

Publications (1)

Publication Number Publication Date
PT1175224E true PT1175224E (pt) 2005-07-29

Family

ID=23178462

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00928604T PT1175224E (pt) 1999-05-04 2000-05-01 Terapeutica de combinacao contra hiv com interferao-alfa peguilado e um antagonista de ccr5

Country Status (21)

Country Link
EP (1) EP1175224B1 (https=)
JP (1) JP2002543144A (https=)
CN (1) CN1349408A (https=)
AR (1) AR023824A1 (https=)
AT (1) ATE289516T1 (https=)
AU (1) AU776541B2 (https=)
BR (1) BR0010593A (https=)
CA (1) CA2365900A1 (https=)
DE (1) DE60018273T2 (https=)
ES (1) ES2238277T3 (https=)
HK (1) HK1039278B (https=)
HU (1) HUP0202734A3 (https=)
MX (1) MXPA01011116A (https=)
MY (1) MY127670A (https=)
NO (1) NO328679B1 (https=)
NZ (1) NZ514519A (https=)
PE (1) PE20010283A1 (https=)
PT (1) PT1175224E (https=)
TW (1) TWI289454B (https=)
WO (1) WO2000066141A2 (https=)
ZA (1) ZA200108870B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050065319A1 (en) * 2000-12-19 2005-03-24 Baroudy Bahige M. Combination method for treating viral infections
WO2004080966A1 (ja) 2003-03-14 2004-09-23 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
US7498323B2 (en) 2003-04-18 2009-03-03 Ono Pharmaceuticals Co., Ltd. Spiro-piperidine compounds and medicinal use thereof
US20070043079A1 (en) * 2003-04-18 2007-02-22 Hiromu Habashita Heterocyclic compound containing nitrogen atom and use thereof
ES2294589T3 (es) 2004-04-29 2008-04-01 F. Hoffmann-La Roche Ag Variacion de la secuencia nucleosida de ns5a como marcador.
EP1790637B1 (en) 2004-09-13 2014-01-29 Ono Pharmaceutical Co., Ltd. Derivatives of N-4-piperidyl urea and medicaments containing them as active ingredient
JP4769257B2 (ja) * 2005-02-23 2011-09-07 シェーリング コーポレイション ケモカインレセプターのインヒビターとして有用なピペリジニルピペラジン誘導体
US20110052612A1 (en) 2005-05-31 2011-03-03 Ono Pharmaceutical Co., Ltd. Spiropiperidine compound and medicinal use thereof
PT1942108E (pt) 2005-10-28 2013-10-24 Ono Pharmaceutical Co Composto com um grupo básico e a sua utilização
WO2007058322A1 (ja) 2005-11-18 2007-05-24 Ono Pharmaceutical Co., Ltd. 塩基性基を含有する化合物およびその用途
KR20090008217A (ko) 2006-03-10 2009-01-21 오노 야꾸힝 고교 가부시키가이샤 질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는 약제
EP2042503B1 (en) 2006-05-16 2013-01-30 Ono Pharmaceutical Co., Ltd. Compound having acidic group which may be protected, and use thereof
WO2008016006A1 (fr) 2006-07-31 2008-02-07 Ono Pharmaceutical Co., Ltd. Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation
WO2010129351A1 (en) 2009-04-28 2010-11-11 Schepens Eye Research Institute Method to identify and treat age-related macular degeneration
EP2741777B1 (en) 2011-08-12 2017-01-18 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical compositions for treatment of pulmonary hypertension
AU2012338581B2 (en) 2011-11-18 2016-12-08 Nxera Pharma Uk Limited Muscarinic M1 receptor agonists
BR112016015736B1 (pt) * 2014-01-08 2022-01-04 Immunovative Therapies, Ltd. Uso de um aloantígeno, uma molécula que interage com receptor de superfície cd40 e citocinas tipo i; e pelo menos um ou mais antígenos de hiv, kit, composição e composição de avi
GB201404922D0 (en) 2014-03-19 2014-04-30 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201513743D0 (en) 2015-08-03 2015-09-16 Heptares Therapeutics Ltd Muscarinic agonists
GB201519352D0 (en) 2015-11-02 2015-12-16 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201617454D0 (en) 2016-10-14 2016-11-30 Heptares Therapeutics Limited Pharmaceutical compounds
GB201810239D0 (en) 2018-06-22 2018-08-08 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201819960D0 (en) 2018-12-07 2019-01-23 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201819961D0 (en) 2018-12-07 2019-01-23 Heptares Therapeutics Ltd Pharmaceutical compounds
GB202020191D0 (en) 2020-12-18 2021-02-03 Heptares Therapeutics Ltd Pharmaceutical compounds
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
PT858343E (pt) * 1995-11-02 2004-07-30 Schering Corp Terapia por infusao continua de uma dose baixa de citoquina
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
GB9609932D0 (en) * 1996-05-13 1996-07-17 Hoffmann La Roche Use of IL-12 and IFN alpha for the treatment of infectious diseases
AU5522498A (en) * 1996-12-13 1998-07-03 Merck & Co., Inc. Substituted aryl piperazines as modulators of chemokine receptor activity
AR013669A1 (es) * 1997-10-07 2001-01-10 Smithkline Beecham Corp Compuestos y metodos

Also Published As

Publication number Publication date
JP2002543144A (ja) 2002-12-17
DE60018273T2 (de) 2005-08-18
MY127670A (en) 2006-12-29
HUP0202734A3 (en) 2003-11-28
NO328679B1 (no) 2010-04-26
ZA200108870B (en) 2003-03-26
HUP0202734A2 (hu) 2002-12-28
TWI289454B (en) 2007-11-11
EP1175224B1 (en) 2005-02-23
BR0010593A (pt) 2002-02-13
EP1175224A2 (en) 2002-01-30
PE20010283A1 (es) 2001-03-16
HK1039278B (en) 2005-06-30
NO20015367L (no) 2002-01-03
CA2365900A1 (en) 2000-11-09
WO2000066141A3 (en) 2001-02-08
AR023824A1 (es) 2002-09-04
AU4681500A (en) 2000-11-17
ES2238277T3 (es) 2005-09-01
AU776541B2 (en) 2004-09-16
DE60018273D1 (de) 2005-03-31
NO20015367D0 (no) 2001-11-02
HK1039278A1 (en) 2002-04-19
WO2000066141A2 (en) 2000-11-09
ATE289516T1 (de) 2005-03-15
MXPA01011116A (es) 2002-06-04
NZ514519A (en) 2003-07-25
CN1349408A (zh) 2002-05-15

Similar Documents

Publication Publication Date Title
PT1175224E (pt) Terapeutica de combinacao contra hiv com interferao-alfa peguilado e um antagonista de ccr5
EP1213397A4 (en) CONNECTED CONSTRUCTION BODY
DE60021099D1 (de) Transdermale, in form einer haftschicht ausgebildete zweifachmedikamenten-verabreichungsvorrichtung
PT1204663E (pt) Novos compostos espiro com actividade antagonista do neuropeptido y
NO993616D0 (no) Anlegg- og kronesystem for bruk med dentalimplantater
FR2796561B1 (fr) Seringue de securite
DE50014413D1 (de) Transdermales therapeutisches system mit neutralisierten acrylhaftklebern
DE60018298D1 (de) Ophtalmologische medikamentenzuführvorrichtung
AU2003252478A1 (en) Ccr4 antagonist and medicinal use thereof
IL151381A0 (en) New ccr5 modulators: benzimidazoles or benzotriazoles
NO20022692D0 (no) Terapeutiske midler
PT1230230E (pt) Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico
NO20014088D0 (no) Varmebeskyttet gjennomforing
DE60019859D1 (de) Dentales Winkelhandstück
DK199900435U3 (da) Farmaceutisk præparat omfattende paroxetin-methansulfonat samt anvendelse heraf
AU2001268653A1 (en) Combination hiv therapy including camptothecin
AU2002239395A1 (en) Hiv treatment with benzimidazoles
DE69934902D1 (de) Medikament gegen drogenabhängigkeit
AU3714800A (en) Hiv therapy
ZA981782B (en) The use of levobupivacaine in combination with other drugs
PT1200409E (pt) Derivados de isoquinolina substituida e a sua utilizacao como anticonvulsivos
FI19992219L (fi) Yhdistetty difibrillaattori ja sydäntahdistin
NO20023003D0 (no) Benzofenon-glykopyranosider, samt fremstilling og terapeutisk anvendelse
SG90049A1 (en) Improvement in the structure of a safety syringe
GB9921248D0 (en) Medicament and assay